American Society for Bone & Mineral Research Annual Meeting 2019 starts tomorrow. Jon Hennings, ARNP and I will be there hoping to see and hear the latest studies about the...
I have let the regular posts to the blog lapse for quite some time, while working on other issues. I have been reviewing my first-time Vertebral Fracture Assessment (VFA) patients. My...
Our Amgen Medical Liaison met with us this week. Her job is to supply information which has been published or presented at major meetings. She meets only with practitioners (MD, NP...
We have “known” for years that 25-hydroxy Vitamin D levels over 50ng/ml are “too high” (hypervitaminosis D) and often cause high Calcium levels (hypercalcemia). The Mayo Clinic designed a...
The question whether calcium supplements are good or bad for you, and how much you should take, is very controversial. That is because it is the wrong question. The answer is...
The American Society for Bone & Mineral Research 35th Annual Meeting has just concluded. Of the roughly 2000 attendees, nearly half were form other countries. Most are PhD researchers dealing...
How can we make Bone Health patient education more effective? An entire office visit only about bone health / osteoporosis prevention and treatment, is an effective start. This I have done...
25-hydroxy Vitamin D level recommendations for patients were plentiful at the American Society for Bone and Mineral Research (ASBMR) 2012 meeting. Many opinions. Little agreement. Research presented was usually observational....
Studies of combinations of osteoporosis medications expanded at the American Society for Bone and Mineral Research (ASBMR) 2012. Previous meetings featured alternating the anabolic, Teriparatide (Forteo) with a Bisphosphonate Antiresorptive, usually...
Vitamin D was the topic of a symposium attended by hundreds of clinicians at the American Society for Bone and Mineral Research (ASBMR) 2012 meeting. Vitamin D3, D2, 25-hydroxy, 1-25-dihydroxy,...